News

Discover more about the recent additions to our portfolio, new partnerships and key company highlights.

CStone signs exclusive license agreement with Istituto Gentili for sugemalimab in Western Europe and the UK

CStone signs exclusive license agreement with Istituto Gentili for sugemalimab ...

Under the terms of the agreement, Gentili will receive exclusive commercialization rights for sugemali...
Czech Republic

Gentili Pharma announces distribution partnership with STADA Pharma CZ for the ...

The partnership establishes STADA as the official partner for the commercialization of Instanyl and Ma...
Istituto Gentili expands its Pain Therapy portfolio

Gentili Pharma enters strategic Nordic partnership with Galen

The partnership will see POA Pharma Scandinavia AB assume exclusive distribution responsibilities acro...